US Patent 9775916 Anti-DLL3 antibody drug conjugates for treating cancer
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+162 characters)
Article
Patent abstract
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
David Liu0
Hui Shao0
Laura Saunders0
Michael Torgov0
Orit Foord0
Robert A. Stull0
Scott J. Dylla0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09775916 Anti-DLL3 antibody drug conjugates for treating cancer US Patent 9775916 Anti-DLL3 antibody drug conjugates for treating cancer
Infobox
Patent Number
097759160
Patent Number
97759160
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
097759160
Date of Patent
October 3, 2017
0Patent Application Number
156089960
Date Filed
May 30, 2017
0Patent Primary Examiner
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09775916 Anti-DLL3 antibody drug conjugates for treating cancer
Infobox
Is a
Patent jurisdiction
Patent number
09775916
Date of patent
October 3, 2017
Patent application number
15608996
Date Filed
May 30, 2017
Patent primary examiner
Find more entities like US Patent 9775916 Anti-DLL3 antibody drug conjugates for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.